Preclinical & Clinical

Whether early-stage discovery or screening current patient populations, the need for novel discovery in medical research and healthcare is immense.
At HMT we provide a collaborative atmosphere working with our clients to find solutions by utilizing the maximum potential of our current platforms and working with our clients to drive new technology development.

Discover how metabolomics can advance your drug discovery program

The Pharmaceutical and Biotech industry utilizes metabolomics in a number of key areas in their drug research and development pipelines.

  • Pre-clinical use of cell lines
  • Bioassays and animal models use metabolomics to validate target engagement,
  • Search for markers of disease progression
  • and much more…

Clinical studies use retroactive/prospective samples from biorepositories or from on-going clinical studies with metabolomic profiles to help find early biomarkers of disease or understand patient stratification.

Application Examples:
Metabolomics Platform with Capillary Electrophoresis Coupled with High-Resolution Mass Spectrometry for Plasma Analysis
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study

Back to Top